Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17801-17850 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03229564
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children
PHASE2Active, not recruiting
12 participants
Started: Oct 25, 2017 · Completed: Jun 30, 2028
1 condition6 sponsors4 locations
NCT03139305
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
PHASE1Active, not recruiting
30 participants
Started: Oct 24, 2017 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT03318094
Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity
PHASE1Active, not recruiting
36 participants
Started: Oct 24, 2017 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT02951130
Milrinone in Congenital Diaphragmatic Hernia
PHASE2Active, not recruiting
66 participants
Started: Oct 24, 2017 · Completed: Mar 31, 2025
4 conditions2 sponsors19 locations
NCT03283878
Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial
PHASE4Active, not recruiting
1,770 participants
Started: Oct 24, 2017 · Completed: Aug 31, 2025
2 conditions3 sponsors14 locations
NCT03373968
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
PHASE2/PHASE3Active, not recruiting
206 participants
Started: Oct 24, 2017 · Completed: Dec 31, 2029
1 condition2 sponsors39 locations
NCT02932410
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
PHASE3Active, not recruiting
165 participants
Started: Oct 24, 2017 · Completed: Nov 30, 2025
1 condition1 sponsor86 locations
NCT03368664
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
PHASE3Active, not recruiting
16 participants
Started: Oct 24, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT03241082
Ultrasound Assessment of BC in the NICU
N/AActive, not recruiting
68 participants
Started: Oct 23, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03296371
Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma
N/AActive, not recruiting
900 participants
Started: Oct 23, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT02958774
Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation
NAActive, not recruiting
388 participants
Started: Oct 23, 2017 · Completed: Mar 1, 2029
1 condition1 sponsor1 location
NCT03126292
Child Development and Primary Care in Low Income Families
NAActive, not recruiting
60 participants
Started: Oct 20, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03241940
Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies
PHASE1Active, not recruiting
33 participants
Started: Oct 20, 2017 · Completed: Aug 1, 2035
7 conditions1 sponsor1 location
NCT03306901
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
NAActive, not recruiting
240 participants
Started: Oct 20, 2017 · Completed: Dec 31, 2033
1 condition2 sponsors9 locations
NCT03382184
Fractional Photothermolysis for Hair Follicle Induction
EARLY_PHASE1Active, not recruiting
50 participants
Started: Oct 20, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03315975
Flu Vaccine Responses in the Setting of Melanoma Treatment
PHASE4Active, not recruiting
40 participants
Started: Oct 20, 2017 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT03179800
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
NAActive, not recruiting
300 participants
Started: Oct 19, 2017 · Completed: May 31, 2025
2 conditions1 sponsor6 locations
NCT03259685
Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome
NAActive, not recruiting
41 participants
Started: Oct 18, 2017 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03891563
Prospective Evaluation of Sport Activity and the Development of Femoroacetabular Impingement in the Adolescent Hip
N/AActive, not recruiting
201 participants
Started: Oct 18, 2017 · Completed: Jul 31, 2025
1 condition5 sponsors4 locations
NCT03249142
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
PHASE1/PHASE2Active, not recruiting
69 participants
Started: Oct 18, 2017 · Completed: Dec 31, 2024
1 condition2 sponsors11 locations
NCT02664701
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts
NAActive, not recruiting
240 participants
Started: Oct 17, 2017 · Completed: Nov 30, 2025
2 conditions1 sponsor9 locations
NCT03570801
SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion
NAActive, not recruiting
662 participants
Started: Oct 17, 2017 · Completed: Dec 31, 2028
4 conditions1 sponsor17 locations
NCT03323463
Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma
PHASE2Active, not recruiting
316 participants
Started: Oct 16, 2017 · Completed: Oct 31, 2025
2 conditions1 sponsor10 locations
NCT03363464
Comparative Effectiveness of Empagliflozin in the US
N/AActive, not recruiting
230,000 participants
Started: Oct 16, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02912559
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
PHASE3Active, not recruiting
700 participants
Started: Oct 16, 2017 · Completed: Jan 17, 2028
4 conditions1 sponsor1054 locations
NCT03070392
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
PHASE2Active, not recruiting
378 participants
Started: Oct 16, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor57 locations
NCT02927912
Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction
PHASE2Active, not recruiting
108 participants
Started: Oct 16, 2017 · Completed: Dec 31, 2025
4 conditions1 sponsor5 locations
NCT03334552
Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.
N/AActive, not recruiting
500 participants
Started: Oct 15, 2017 · Completed: Aug 31, 2024
1 condition4 sponsors1 location
NCT04257994
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
N/AActive, not recruiting
26 participants
Started: Oct 15, 2017 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT03393832
Oral Care in Infants With Gastroschisis
N/AActive, not recruiting
27 participants
Started: Oct 14, 2017 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03121456
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
NAActive, not recruiting
74 participants
Started: Oct 13, 2017 · Completed: Apr 12, 2024
1 condition1 sponsor1 location
NCT03223779
Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
52 participants
Started: Oct 13, 2017 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03281369
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
PHASE1/PHASE2Active, not recruiting
410 participants
Started: Oct 13, 2017 · Completed: Nov 30, 2025
1 condition3 sponsors27 locations
NCT03233347
Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
PHASE2Active, not recruiting
82 participants
Started: Oct 13, 2017 · Completed: Jul 8, 2026
7 conditions2 sponsors9 locations
NCT03303846
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
NAActive, not recruiting
344 participants
Started: Oct 13, 2017 · Completed: Apr 25, 2026
1 condition2 sponsors5 locations
NCT03168776
PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease
NAActive, not recruiting
1,632 participants
Started: Oct 13, 2017 · Completed: Sep 30, 2024
1 condition2 sponsors58 locations
NCT03019406
A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa
PHASE2Active, not recruiting
22 participants
Started: Oct 12, 2017 · Completed: Dec 30, 2026
1 condition1 sponsor12 locations
NCT03288545
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
PHASE1/PHASE2Active, not recruiting
348 participants
Started: Oct 11, 2017 · Completed: Sep 11, 2026
7 conditions3 sponsors106 locations
NCT03148327
Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Oct 11, 2017 · Completed: Jun 1, 2027
1 condition2 sponsors4 locations
NCT03213275
The Premature Gut Microbiome and the Influence on Neonatal Immunity, Brain Development and White Matter Injury
N/AActive, not recruiting
60 participants
Started: Oct 11, 2017 · Completed: Sep 28, 2026
3 conditions2 sponsors1 location
NCT05222854
"Comprehensive Genomic Profiling Combined With Real Life Data of The German-Registry of Incidental Gallbladder Carcinoma"
N/AActive, not recruiting
200 participants
Started: Oct 11, 2017 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT03298451
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
PHASE3Active, not recruiting
1,324 participants
Started: Oct 11, 2017 · Completed: Aug 27, 2026
1 condition1 sponsor160 locations
NCT02856893
Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)
PHASE2Active, not recruiting
156 participants
Started: Oct 10, 2017 · Completed: Dec 31, 2027
1 condition2 sponsors22 locations
NCT03268603
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
PHASE2Active, not recruiting
75 participants
Started: Oct 10, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors3 locations
NCT03315910
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
PHASE4Active, not recruiting
807 participants
Started: Oct 10, 2017 · Completed: Oct 31, 2026
1 condition2 sponsors18 locations
NCT03211663
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
N/AActive, not recruiting
269 participants
Started: Oct 9, 2017 · Completed: Dec 1, 2025
3 conditions1 sponsor5 locations
NCT04747847
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease
EARLY_PHASE1Active, not recruiting
10 participants
Started: Oct 9, 2017 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT03330132
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
PHASE4Active, not recruiting
1,861 participants
Started: Oct 7, 2017 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03014167
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
PHASE3Active, not recruiting
502,363 participants
Started: Oct 4, 2017 · Completed: May 31, 2024
2 conditions10 sponsors3 locations
NCT03275051
Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)
NAActive, not recruiting
9 participants
Started: Oct 4, 2017 · Completed: Jun 1, 2026
1 condition2 sponsors1 location